No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
299 |
4. Check minimum number of eventsNone |
299 |
5. Include endpointsNone |
299 |
6. Filter based on genotype QC (FinnGen only) |
299 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Aliae malformationes congenitae membrorum
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of limb(s)
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4390 | 2208 | 2179 |
| Only index persons | 3749 | 1902 | 1847 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.06 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 10.78 | 11.62 | 9.91 |
| Only index persons | 11.95 | 12.39 | 11.49 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 299 | 207 | 92 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 14.08 | 13.78 | 14.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 261
- Matched controls
- 2610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q74.1
ICD-10 Finland
Congenital malformation of knee
+∞
68.9
63
*
Q74.88
ICD-10 Finland
Other specified congenital malformations of limb(s)
411.2
37.0
36
*
Q74.83
ICD-10 Finland
Congenital limb asymmetri, unspecified
+∞
29.8
28
*
Q74.9
ICD-10 Finland
Unspecified congenital malformation of limb(s)
+∞
24.3
23
*
Q74.81
ICD-10 Finland
Congenital overgrowth of limb(s)
+∞
22.2
21
*
NFK20
NOMESCO Finland
Epiphysiodesis of femur
62.7
20.2
23
*
Q74.01
ICD-10 Finland
Madelung's deformity
+∞
17.9
17
*
Q74.3
ICD-10 Finland
Arthrogryposis multiplex congenita
+∞
16.8
16
*
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
18.7
15.9
24
14
Q74.82
ICD-10 Finland
Congenital undergrowth of limb(s)
+∞
15.8
15
*
Z31.5
ICD-10 Finland
Genetic counselling
5.2
12.8
41
91
Q74.80
ICD-10 Finland
Congenital brachydactyli
+∞
12.6
12
*
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
+∞
12.6
12
*
Q74.28
ICD-10 Finland
Other congenital malformations of lower limb(s), including pelvic girdle
+∞
11.5
11
*
NGK20
NOMESCO Finland
Epiphysiodesis of knee or lower leg
125.3
11.5
12
*
L82
ICPC
Congenital anomaly musculoskeletal
+∞
10.5
10
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
9.7
10.2
20
22
ZXA10
NOMESCO Finland
Bilateral
3.3
9.5
52
185
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
18.4
9.5
14
8
Q68.8
ICD-10 Finland
Other specified congenital musculoskeletal deformities
103.6
9.5
10
*
Q74.00
ICD-10 Finland
Accessory carpal bones
+∞
9.4
9
*
Q66.0
ICD-10 Finland
Talipes equinovarus
+∞
9.4
9
*
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
38.1
9.1
11
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.8
8.4
60
253
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
8.6
8.2
17
21
M25.5
ICD-10 Finland
Pain in joint
2.4
8.2
78
390
R4110
NOMESCO Finland
Physiotherapy
2.4
8.0
76
376
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
12.4
7.7
13
11
SPAT1229
SPAT
Assessment of need for aid
7.2
7.4
17
25
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
7.3
95
544
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
6.8
98
584
M17.1
ICD-10 Finland
Other primary gonarthrosis
4.1
6.7
25
66
M21.7
ICD-10 Finland
Unequal limb length (acquired)
14.8
6.4
10
7
9165
FHL
Removal of osteosynthesis material
18.6
6.3
9
5
Q74.02
ICD-10 Finland
Cleidocranial dysostosis
+∞
6.3
6
*
Q74.20
ICD-10 Finland
Congenital fusion of sacroiliac joint
+∞
6.3
6
*
Q74.2
ICD-10 Finland
Other congenital malformations of lower limb(s), including pelvic girdle
+∞
6.3
6
*
TNH36
NOMESCO Finland
Custom molded cast of pes equinovarus
+∞
6.3
6
*
Q68.1
ICD-10 Finland
Congenital deformity of hand
+∞
6.3
6
*
75598
ICD-8 Finland
Other congenital anomalies of limbs, Alia definita
+∞
6.3
6
*
9472
FHL
Soft tissue biopsy (muscle, tumor) under general anesthesia or operating room
+∞
6.3
6
*
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
27.4
6.3
8
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
6.1
55
264
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
53
232
2.56
8.01
2.5
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
73
388
2.17
7.04
4.0
3.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
246
2.35
6.60
1.9
2.1
nmol/l
392.2
382.8
0.10
47
229
(3002256) Pathology report gross observation
46
215
2.35
5.99
1.3
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
32
128
2.68
5.76
5.0
5.7
ng/l
78.8
64.5
0.21
32
119
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
105
680
1.84
5.62
4.2
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
40
3.90
5.15
1.8
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
96
620
1.81
5.11
4.0
3.1
e6/l
21.1
50.4
1.17
74
462
(3030467) Casts [#/volume] in Urine by Automated count
88
554
1.83
5.08
3.9
3.1
e6/l
0.3
0.2
0.24
62
405
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
345
1.96
4.87
3.1
2.8
e6/l
2.2
0.6
1.17
33
193
(3007853) Bacteria identified in Skin by Aerobe culture
49
257
2.08
4.80
1.9
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
177
1389
1.67
4.47
8.5
9.2
e9/l
4.1
3.8
0.91
154
1210
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
107
2.57
4.44
2.3
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
160
1227
1.65
4.39
7.2
6.7
e9/l
0.6
0.5
0.52
139
1067
(36304419) Bacteria [Presence] in Urine
87
568
1.75
4.37
4.0
3.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
160
1230
1.65
4.33
7.2
6.7
e9/l
0.0
0.0
0.01
139
1070
(3013115) Eosinophils [#/volume] in Blood
164
1271
1.64
4.28
7.3
7.3
e9/l
0.2
0.2
0.54
147
1134
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
114
810
1.66
4.16
13.6
7.8
mmol/l
1.2
1.2
1.24
108
755
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
86
2.68
4.15
1.7
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
109
767
1.66
4.13
4.9
3.7
e6/l
74.3
43.9
0.52
78
490
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
334
1.87
4.07
3.3
2.9
e6/l
2.3
3.1
0.48
28
184
(3019198) Lymphocytes [#/volume] in Blood
164
1291
1.60
3.86
7.1
6.6
e9/l
2.0
2.1
0.61
147
1154
(3024561) Albumin [Mass/volume] in Serum or Plasma
99
703
1.61
3.52
6.7
5.3
g/l
35.9
37.7
2.27
88
667
(3018418) pH of Serum or Plasma
71
464
1.70
3.49
3.9
3.4
ph
7.4
7.4
—
10
75
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
128
2.22
3.42
1.4
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
77
520
1.65
3.33
3.1
3.2
mmol/l
8.5
8.6
0.10
71
460
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
179
1469
1.54
3.30
6.9
5.8
u/l
84.5
85.7
0.10
174
1378
(3019069) Monocytes/100 leukocytes in Blood
150
1186
1.53
3.27
7.2
6.9
%
8.1
8.0
0.24
140
1135
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
121
915
1.54
3.23
4.9
5.6
umol/l
11.1
13.0
0.48
115
864
(4062490)
10
28
3.66
3.22
3.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
63
408
1.69
3.18
3.5
2.5
e6/l
6.3
6.8
0.16
53
354
(3018010) Neutrophils/100 leukocytes in Blood
154
1231
1.52
3.15
7.0
6.4
%
55.3
53.7
1.03
145
1176
(3023103) Potassium [Moles/volume] in Serum or Plasma
249
2220
1.73
3.13
16.2
9.6
mmol/l
3.9
3.9
0.17
242
2140
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
134
1042
1.52
3.12
4.0
3.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
144
1137
1.51
3.11
7.3
6.9
%
0.6
0.7
1.55
135
1081
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
513
1.62
3.06
3.2
3.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
155
1249
1.50
3.01
7.1
6.6
%
30.4
32.2
1.36
146
1197
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
5
10.14
2.99
2.0
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
147
1178
1.49
2.89
7.2
6.7
%
2.9
2.9
0.09
137
1118
(3013826) Glucose [Moles/volume] in Serum or Plasma
150
1207
1.49
2.89
8.5
4.7
mmol/l
6.2
6.2
0.08
136
1067
(40758558) Short blood count panel - Blood
88
633
1.55
2.89
5.8
7.1
—
—
—
0
0
(3026782) Osmolality of Urine
59
386
1.66
2.86
3.3
2.5
mosm/kgh2o
575.8
565.9
0.09
48
323
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
289
1.74
2.85
1.8
1.6
pmol/l
400.6
26070474.2
0.50
37
257
(42870588) Differential panel, method unspecified - Blood
108
815
1.51
2.84
7.0
7.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
212
1.85
2.83
12.0
7.8
mmol/l
1.1
0.9
0.23
25
147
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
117
899
1.50
2.81
10.9
7.5
mmol/l
1.2
1.2
1.24
106
783
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
42
2.93
2.78
1.1
2.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
37
214
1.83
2.75
12.1
7.8
kpa
5.0
5.0
0.05
37
203
(3026008) Bacteria identified in Urine by Culture
82
590
1.54
2.67
3.0
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
36
210
1.81
2.61
1.5
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
9
25
3.68
2.59
3.3
4.0
%
9.7
8.8
—
9
25
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
11
5.54
2.55
1.2
1.6
u/l
7.4
9.8
—
6
11
(3026493) Urate [Moles/volume] in Serum or Plasma
58
389
1.61
2.55
3.0
3.3
umol/l
313.0
3169.5
1.08
52
352
(3000492) Spirometry study
37
220
1.78
2.52
1.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
114
888
1.46
2.50
3.4
2.5
nmol/l
70.7
70.5
0.02
109
821
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
41
252
1.73
2.50
2.4
2.3
mmol/l
2.5
2.4
1.37
31
214
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
9
26
3.54
2.50
3.3
3.8
%
20.6
27.4
—
9
26
(3003396) Base excess in Arterial blood by calculation
25
131
1.99
2.49
24.0
7.2
mmol/l
-0.2
0.7
0.65
16
101
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
16
4.45
2.49
1.7
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
254
1.71
2.43
1.6
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
27
3.40
2.41
3.9
3.7
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
9
27
3.40
2.41
3.3
4.1
%
25.0
13.2
—
9
27
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
8
6.33
2.38
2.0
1.5
nmol/l
77.4
51.6
—
5
8
(3037467) Urinalysis macro (dipstick) panel - Urine
183
1573
1.42
2.26
4.7
3.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
181
1.80
2.26
1.7
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
9
5.63
2.22
2.8
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
30
3.06
2.16
6.1
20.6
%
76.2
73.5
—
9
30
(3000991) Gas panel - Venous blood
35
215
1.71
2.15
18.9
8.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
36
223
1.70
2.15
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
177
1.77
2.12
1.7
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
38
240
1.67
2.11
7.1
8.6
mmol/l
1.6
1.3
0.28
32
184
(3021901) Oxygen saturation in Capillary blood
9
31
2.96
2.09
2.2
4.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
22
118
1.93
2.08
27.0
7.6
%
96.3
96.1
0.06
22
110
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
20
3.56
2.06
1.7
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
28
164
1.78
2.03
14.0
8.5
kpa
9.9
9.8
0.30
28
158
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
181
1.73
1.97
7.7
9.6
mmol/l
24.2
23.7
0.50
30
174
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
27
3.02
1.95
1.6
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
174
1.74
1.95
1.5
1.8
iu/l
13.9
15.0
0.08
21
133
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
78
2.11
1.94
1.2
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
81
617
1.43
1.94
1.7
1.6
pmol/l
97.2
98.5
0.08
40
328
(3052851) Hemolysis interference index of Serum or Plasma
12
52
2.36
1.90
2.3
2.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
231
1.63
1.90
2.4
2.5
%
21.3
24.8
0.68
29
209
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
92
724
1.39
1.82
4.0
3.4
u/l
30.3
29.3
0.16
87
693
(3015377) Calcium [Moles/volume] in Serum or Plasma
76
579
1.42
1.81
2.4
2.6
mmol/l
2.4
2.4
0.14
66
521
(3028271) Lactate [Moles/volume] in Capillary blood
7
23
3.09
1.81
2.0
2.1
mmol/l
1.2
1.7
—
7
23
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
29
178
1.70
1.81
14.1
8.1
mmol/l
24.3
24.1
0.18
29
178
(3023420) DNA double strand Ab [Units/volume] in Serum
8
29
2.81
1.80
1.8
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
190
1678
1.36
1.80
4.6
3.7
mmol/mol
37.3
37.2
0.07
183
1587
(3048689) Calprotectin [Mass/mass] in Stool
60
439
1.46
1.77
2.5
3.0
ug/g
115.1
82.8
0.35
52
340
(3032080) INR in Blood by Coagulation assay
72
546
1.42
1.76
7.1
4.9
inr
1.1
1.1
0.21
24
175
(3024354) Oxygen [Partial pressure] in Venous blood
34
220
1.62
1.74
7.6
8.8
kpa
5.4
5.1
0.30
34
214
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.1
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
241
2220
1.44
1.72
18.3
12.5
%
13.5
13.2
1.35
234
2187
(3002173) Hemoglobin [Mass/volume] in Arterial blood
19
104
1.88
1.71
30.8
7.7
g/l
122.8
123.8
0.06
19
97
(3020682) Albumin/Creatinine [Ratio] in Urine
46
324
1.50
1.64
4.6
4.4
mg/mmol
2.8
16.9
2.96
35
220
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
483
1.41
1.60
1.5
1.7
mmol/l
1.5
1.4
0.34
57
431
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
466
1.42
1.59
3.3
2.6
mg/l
1.3
0.8
0.68
49
330
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
208
1881
1.35
1.57
11.0
7.4
ml/min/173m2
101.3
99.8
0.42
160
1407
(3021589) Normoblasts [#/volume] in Blood
135
1150
1.32
1.55
10.5
8.6
e9/l
0.0
0.0
0.00
109
920
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
37
253
1.53
1.52
3.8
4.3
umol/l
5.7
9.0
0.91
29
209
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
21
2.89
1.51
3.8
1.2
nmol/l
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
21
2.89
1.51
2.7
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
132
1.72
1.50
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
189
1.59
1.46
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
66
2.01
1.45
11.1
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
131
1120
1.30
1.44
3.5
3.0
estimate
0.0
0.0
0.00
20
226
(3028026) IgM [Mass/volume] in Serum or Plasma
25
158
1.64
1.43
2.7
1.8
g/l
1.0
1.1
0.35
25
145
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
216
1.54
1.40
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
82
1.87
1.38
1.9
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
42
302
1.45
1.37
2.9
2.4
u/l
8116.3
2981.6
0.41
18
133
(3013707) Erythrocyte sedimentation rate by Westergren method
181
1622
1.29
1.36
5.2
3.7
mm/h
10.1
8.2
1.24
170
1512
(3035637) Corticotropin [Mass/volume] in Plasma
10
47
2.17
1.35
1.7
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
121
1.70
1.34
3.0
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
27
177
1.58
1.34
15.7
8.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
43
312
1.44
1.34
3.3
3.6
mg/l
1375.7
118.3
0.45
33
211
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
205
1870
1.31
1.34
4.4
3.9
pmol/l
14.4
14.4
0.13
195
1728
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
24
2.53
1.31
1.8
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
3.7
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
162
1.59
1.31
1.5
1.9
u/l
5.5
7.7
1.00
16
121
(3044640) Blood type and Crossmatch panel - Blood
81
656
1.32
1.30
2.7
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
65
510
1.35
1.29
3.1
3.1
kg/l
1.0
1.0
—
8
71
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.0
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
16
92
1.78
1.27
3.1
2.6
e6/l
0.2
0.2
0.27
16
87
(3009261) Glucose [Presence] in Urine by Test strip
131
1134
1.28
1.27
3.5
3.1
estimate
0.0
0.0
0.00
16
223
(3017446) Testosterone [Moles/volume] in Serum or Plasma
23
147
1.61
1.27
1.6
2.1
nmol/l
12.4
12.4
0.00
17
129
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
36
256
1.46
1.25
7.1
4.2
ng/l
1544.9
697.0
0.47
26
206
(3014051) Protein [Presence] in Urine by Test strip
9
45
2.03
1.24
2.4
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
45
2.03
1.24
2.0
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
267
2544
1.46
1.23
13.1
8.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
19
2.66
1.22
2.0
1.7
%
91.6
92.7
—
5
19
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
50
2.03
1.18
5.3
7.5
—
647.7
—
0
9
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
232
2167
1.32
1.17
5.0
4.4
mu/l
1.8
2.3
0.49
220
2042
(40768804) Tissue Pathology biopsy report
91
761
1.28
1.15
1.8
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
51
1.99
1.12
1.7
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
256
2431
1.37
1.11
10.0
7.8
u/l
29.6
25.2
1.75
248
2352
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
153
1.55
1.10
2.5
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
33
2.15
1.06
7.6
19.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
75
1.77
1.04
2.1
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
127
1120
1.23
1.00
4.8
4.4
estimate
0.0
0.0
0.00
20
234
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
166
1.48
0.98
1.6
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
279
1.37
0.96
4.2
2.6
ng/l
303.3
480.4
0.34
25
145
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
51
1.79
0.95
1.8
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
62
506
1.28
0.95
2.8
2.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
27
193
1.44
0.94
6.6
2.8
g/l
10.5
9.7
0.46
27
176
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
52
1.75
0.93
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
168
1.47
0.93
3.1
4.7
g/l
0.2
0.2
0.02
24
161
(3017143) Hepatitis C virus Ab [Presence] in Serum
54
434
1.30
0.92
1.6
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
6
28
2.17
0.92
2.7
2.6
—
819.0
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
71
1.72
0.90
47.1
7.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
89
763
1.24
0.90
1.9
1.5
g/l
2.2
1.9
0.67
54
441
(3029937) Albumin [Presence] in Urine by Test strip
70
585
1.26
0.88
3.6
3.1
estimate
0.0
0.0
0.50
18
232
(4306422)
8
44
1.84
0.86
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
375
1.30
0.85
1.3
1.3
iu/ml
10.6
23.8
—
10
107
(1616796) Gas panel - Central venous blood
6
31
1.95
0.85
7.8
2.9
—
—
—
0
0
(3015736) pH of Urine
103
904
1.21
0.83
2.9
2.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
89
1.60
0.82
2.6
1.6
g/l
0.2
0.2
0.82
14
83
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
47
1.72
0.81
2.4
4.3
u/ml
3.4
7.0
—
8
40
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
61
508
1.25
0.80
2.8
2.3
ng/l
20.5
26.6
0.30
26
204
(3021387) Prolactin [Units/volume] in Serum or Plasma
27
200
1.38
0.79
1.6
1.4
mu/l
258.2
305.1
0.77
27
180
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
123
1.49
0.79
2.3
2.0
ml/min/173m2
69.1
84.0
—
7
46
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
68
576
1.23
0.77
4.9
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
2.8
1.7
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
24
2.10
0.75
5.4
5.2
ug/l
1.6
2.5
—
5
24
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.2
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.1
1.5
—
—
—
0
0
(4268621)
7
38
1.86
0.74
3.4
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
60
1.69
0.73
1.6
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
428
0.77
0.72
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
133
1208
1.18
0.72
3.1
2.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
14
93
1.53
0.71
2.6
1.6
g/l
1.1
1.2
0.34
14
86
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
203
0.67
0.70
1.6
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
5
27
1.87
0.68
1.0
1.2
u/ml
0.5
1.0
—
5
20
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
574
1.22
0.68
2.6
2.6
mg/l
2.8
2.7
0.17
61
496
(3007461) Platelets [#/volume] in Blood
285
2788
1.47
0.68
20.7
14.3
e9/l
268.6
261.5
1.05
279
2708
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
280
0.73
0.66
1.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
87
1.52
0.64
1.5
1.7
—
—
—
0
0
(44806118)
5
29
1.74
0.64
2.4
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.74
0.64
1.2
1.6
—
—
—
0
0
(44790047)
5
29
1.74
0.64
2.4
1.5
—
—
—
0
0
(44790048)
5
29
1.74
0.64
2.4
1.5
—
—
—
0
0
(44790049)
5
29
1.74
0.64
2.4
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
95
847
1.18
0.63
3.2
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
225
2344
0.84
0.62
3.8
3.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
30
1.68
0.61
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
285
2793
1.44
0.61
20.7
14.3
e12/l
4.6
4.6
0.85
279
2715
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
95
850
1.17
0.60
1.7
1.5
u/ml
0.6
2.2
1.81
20
200
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
204
1935
1.17
0.60
3.7
2.9
mmol/l
5.7
5.5
0.53
186
1792
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
8
54
1.49
0.57
4.8
5.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
285
2797
1.40
0.55
20.7
14.3
e9/l
7.1
6.7
2.30
279
2715
(3003694) ABO and Rh group [Type] in Blood
100
906
1.16
0.54
1.6
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
324
0.78
0.53
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
261
1.25
0.52
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
252
2443
1.20
0.52
15.3
9.6
mg/l
22.7
20.1
0.52
194
1774
(3003327) Ova and parasites identified in Stool by Light microscopy
16
118
1.38
0.51
1.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
693
0.85
0.51
1.8
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
67
1.51
0.50
1.5
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
375
1.20
0.49
1.2
1.2
u/ml
3.2
8.9
1.24
14
151
(3004588) Protein electrophoresis panel - Serum or Plasma
7
47
1.50
0.48
1.1
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
47
1.50
0.48
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
35
294
1.22
0.45
2.5
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
165
1562
1.13
0.44
3.3
3.1
u/l
41.4
31.0
0.83
156
1505
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
56
1.44
0.43
1.0
1.3
—
57.1
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
94
0.63
0.43
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
96
1.37
0.42
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
114
1.33
0.41
1.5
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
205
1972
1.13
0.40
3.9
3.3
mmol/l
2.9
2.8
1.25
194
1855
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
104
0.67
0.40
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
35
1.44
0.39
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
170
0.75
0.39
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
80
1.39
0.39
3.7
2.9
ng/l
147.5
114.6
0.10
11
75
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
80
1.39
0.39
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
225
1.22
0.38
1.8
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
1.2
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
72
1.40
0.37
1.1
1.1
u/ml
1.5
8.9
—
5
36
(3020874) Milk IgE Ab [Units/volume] in Serum
5
37
1.36
0.37
1.0
1.3
u/ml
0.9
2.7
—
5
20
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
70
1.29
0.37
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
70
1.29
0.37
2.3
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
70
1.29
0.37
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
36
311
1.18
0.36
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
12
90
1.35
0.36
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
126
0.71
0.35
5.1
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
42
369
1.16
0.35
1.9
1.6
%
1.3
1.4
0.30
37
334
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
45
1.34
0.34
2.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
597
0.88
0.32
1.7
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
239
0.83
0.31
1.4
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
55
1.28
0.30
4.4
2.0
nmol/l
1.1
0.7
—
7
46
(3044290) Cell count panel - Cerebral spinal fluid
8
63
1.28
0.28
1.6
3.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
63
1.28
0.28
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
122
1.24
0.27
1.4
1.5
—
—
—
0
0
(4034850)
8
65
1.24
0.27
6.9
7.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
251
2463
1.12
0.26
16.7
11.0
%
40.4
40.2
0.23
204
2108
(4035726)
15
123
1.23
0.26
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
203
1975
1.09
0.25
3.7
3.2
mmol/l
4.7
4.6
0.42
192
1871
(40768443) Skin Pathology biopsy report
9
77
1.17
0.24
1.6
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
78
1.29
0.24
1.5
2.0
u/l
41.3
39.7
—
10
72
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
152
1.20
0.24
3.5
3.3
%
21.1
22.1
—
7
41
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
115
1.23
0.24
3.3
3.6
umol/l
5.7
9.8
—
9
87
(1761868) Lipid panel - Serum or Plasma
74
789
0.92
0.23
2.7
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
38
1.32
0.23
1.8
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
97
1.25
0.23
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
153
1.19
0.23
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
528
1.10
0.22
2.3
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
40
1.25
0.22
1.8
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
40
1.25
0.22
2.2
4.5
umol/l
38.4
42.3
—
5
35
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
989
0.93
0.21
2.3
2.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
42
1.19
0.21
1.0
3.4
e9/l
4.0
3.5
—
5
42
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
3.9
—
101.5
—
0
11
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
6.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.3
—
0
10
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
43
1.17
0.21
1.0
3.5
%
59.2
54.2
—
5
43
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
43
1.17
0.21
1.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
43
1.17
0.21
27.2
4.6
%
2.1
1.6
—
5
36
(4010399)
14
117
1.21
0.21
1.1
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
1071.0
—
0
13
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
176
0.84
0.20
1.3
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
50
1.20
0.20
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
50
1.20
0.20
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
137
1.18
0.19
1.5
2.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
60
1.17
0.18
2.1
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
200
1958
1.06
0.17
3.5
3.1
mmol/l
1.4
1.5
2.24
190
1847
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
51
545
0.92
0.17
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
204
0.87
0.16
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
297
0.90
0.16
1.3
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
297
0.90
0.16
1.3
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
77
0.77
0.16
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
226
1.12
0.15
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
79
0.75
0.15
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
10
119
0.83
0.15
1.1
1.1
u/ml
0.1
5.2
—
5
30
(42529406) Shigella sp [Presence] in Stool by Culture
6
80
0.74
0.15
1.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
236
1.11
0.15
1.3
1.3
iu/ml
65.2
139.1
—
10
90
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
171
0.87
0.15
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
171
0.87
0.15
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
659
1.06
0.13
2.9
2.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
180
0.88
0.13
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
299
0.93
0.09
1.3
1.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
46
1.09
0.09
1.2
1.5
—
—
—
0
0
(3013512) EKG study
40
380
1.06
0.09
3.1
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
48
1.04
0.09
2.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
298
0.93
0.09
1.3
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
165
0.90
0.09
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
165
1.10
0.09
5.4
5.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
81
834
0.96
0.09
2.3
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
100
976
1.04
0.08
2.2
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.2
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
10
88
1.14
0.08
1.1
1.1
u/ml
0.2
6.6
—
5
36
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
64
1.10
0.08
1.3
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
72
0.83
0.07
1.7
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
74
0.81
0.07
4.0
2.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
75
0.80
0.07
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
75
0.80
0.07
1.0
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
8
75
1.07
0.07
1.3
1.6
—
0.0
—
0
16
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.5
2.7
e6/l
67.5
105.4
—
8
63
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.5
2.6
e6/l
1.5
7.0
—
8
59
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
780
0.97
0.07
1.9
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
275
0.94
0.07
1.3
2.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
213
0.93
0.06
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
213
0.93
0.06
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
213
0.93
0.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
213
0.93
0.06
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
119
1.10
0.06
1.8
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
119
1.10
0.06
1.1
1.1
u/ml
4.1
5.5
—
7
86
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
428
1.03
0.04
2.0
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
220
1.05
0.03
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
128
0.93
0.02
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
14
132
1.06
0.02
2.8
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
188
1870
1.01
0.02
3.3
2.9
mmol/l
1.3
1.2
1.52
178
1766
(3050129) First trimester maternal screen panel - Serum or Plasma
29
282
1.03
0.02
1.5
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
117
0.94
0.02
1.1
1.1
u/ml
0.1
1.4
—
5
74
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
767
0.99
0.01
2.1
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
13
136
0.95
0.00
3.7
3.4
e9/l
49.5
66.8
—
8
94
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
231
1.00
0.00
1.1
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
157
1.02
0.00
2.1
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
207
1.02
0.00
4.6
3.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
116
1.04
0.00
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
206
1.02
0.00
1.1
2.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
69
0.87
0.00
1.5
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
26.0
—
0.6
—
0
9
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
91
0.99
0.00
1.1
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
14.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
96
0.94
0.00
2.0
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
98
0.92
0.00
2.3
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
9.2
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
64
0.94
0.00
1.7
1.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
6.3
—
0
6
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
54
0.92
0.00
4.4
2.6
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
7.0
—
49.5
—
0
7
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_LIMBS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_LIMBS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_LIMBS – Other congenital malformations of limb(s)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data